FDA campaign H-0442-2026
Class IIIHazard
The firm initiated a voluntary recall after NSF testing showed that labeled ingredient quantities did not align with analytical test results, manganese level was below label quantity.
Distribution
Nationwide via Amazon distribution
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.